Financial Regulation

A new poll reveals overwhelming public opposition to a federal plan to stockpile glyphosate, fueled by billions in lawsuits and a retracted safety study.

The digital marketplace aims to bring transparency and efficiency to Hong Kong’s fragmented private lending sector, connecting borrowers with licensed lenders.

Pennsylvanians lost over $285 million to scams in one year. AARP is now urging residents to break the silence and report fraud to protect others.

With its Q platform, PMSI is tackling decades of inefficiency, promising to restore trust and transparency to the complex world of mortgage servicing.

A new alliance aims to fight fraud and empower users with a single, secure digital ID for an increasingly complex physical and digital world.

Amid a strategic overhaul, Hepion Pharmaceuticals is licensing a novel RNA-based liquid biopsy, aiming to transform early liver cancer detection.

The new M² card aims to redefine crypto spending with self-custody, user-approved transactions, and a deep integration with decentralized digital identity.

A new report reveals 67% of asset servicing errors stem from bad data. With volumes soaring, firms face a choice: comply with ISO 20022 or transform.

Peli BioThermal and Polar Group partner to upgrade Brazil's pharma logistics, tackling a booming market and ensuring safer delivery of advanced medicines.

EcoVadis awards highlight a major shift: sustainability is no longer about compliance, but a core driver of performance, resilience, and long-term value.

Lantheus gains FDA tentative approval for a LUTATHERA rival, signaling new hope for rare cancer patients and a legal battle with Novartis over market access.

Fresh off a major clinical trial victory, Alumis Inc. heads to a key investor conference. What's next for its promising pipeline and soaring stock?

A $1M deal offers a sliver of recovery for victims of the $71M William Jordan Ponzi scheme, putting custodian Kingdom Trust's alleged role in focus.

Total Joint Orthopedics surpasses 50,000 implants, signaling a major shift as surgeries move from hospitals to efficient, cost-effective surgery centers.

Lynk Pharmaceuticals reports its oral drug zemprocitinib met all goals in a late-stage study for atopic dermatitis, offering rapid itch relief and a strong safety profile.

A class action lawsuit alleges hospital operator Ardent Health misled investors by hiding financial risks, leading to a 33% stock price collapse.

As state attorneys general ramp up multi-state investigations, Stateside Associates brings on a seasoned expert to help clients navigate the complex landscape.

Former top U.S. banking regulator Rodney E. Hood joins Northpointe's board, bringing deep expertise to the mortgage-focused bank's strategic goals.

A new oral therapy, mavorixafor, receives a key recommendation in Europe, offering a beacon of hope for patients with a debilitating ultra-rare immune disorder.

Cirrus Nexus's TrueCarbon platform lands on Microsoft Marketplace, offering AI-driven tools to slash cloud bills and environmental impact simultaneously.